Brief Cognitive Behavioral Therapy Replication Trial
Launched by UNIVERSITY OF UTAH · Dec 5, 2018
Trial Information
Current as of November 14, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This trial is testing whether a short, structured talk therapy called Brief Cognitive Behavioral Therapy (BCBT) can help prevent suicide attempts in U.S. military personnel and veterans who are currently thinking about suicide or have recently tried to harm themselves. Participants are randomly assigned to receive either BCBT or Present-Centered Therapy (PCT). Everyone also continues to receive standard mental health care as usual. The study follows people for about 2 years after treatment to see if there are fewer suicide attempts and less severe suicidal thoughts with BCBT compared with PCT.
To be eligible, adults must have served in the U.S. military and either be actively thinking about suicide or have had a suicide attempt within the past two weeks. They must be able to understand English and give informed consent. Exclusions include conditions that would make participation unsafe or unable to complete the study, such as psychosis, mania, or serious intoxication. The therapy consists of 12 sessions (the first session is longer) delivered at multiple sites, with safety planning and ongoing care provided as part of usual services. The primary outcome is the change in the number of suicide attempts over about 2 years; the main secondary outcome is changes in suicidal thoughts over the same period, measured with standard interviews and scales.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Current or past service in the U.S. military
- • 18 years of age or older
- • Reporting current suicide ideation with intent to die and/or a suicide attempt within the past two weeks
- • Ability to understand and speak the English language; and ability to complete the informed consent process.
- Exclusion Criteria:
- • Psychiatric or medical condition that precludes the ability to provide informed consent or participation in outpatient treatment (e.g., psychosis, mania, acute intoxication).
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Jacksonville, North Carolina, United States
Charleston, South Carolina, United States
Patients applied
Trial Officials
Craig J Bryan, PsyD, ABPP
Principal Investigator
Ohio State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials